Effect of Carvedilol on Ambulatory Blood Pressure, Renal Hemodynamics, and Cardiac Function in Essential Hypertension

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-198706111-00024PMID 2454359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Beta-blockers and chronic kidney disease: a literature review

  2024cites this paper
• Carvedilol: New pharmacological approaches

  2024cites this paper
• Hypertensive Chronic Kidney Disease

  2019cites this paper
• The effect of vasodilator &bgr;-blockers on renal function in hypertensive patients

  2017cites this paper
• Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.

  2015cites this paper
• A systematic review of the blood pressure lowering efficacy of beta blockers for primary hypertension

  2014cites this paper
• Beta and Angiotensin Blockades Are Associated With Improved 10‐Year Survival in Renal Transplant Recipients

  2013cites this paper
• Transdermal Delivery of Prepared Inclusion Complexes of Carvedilol with Cyclodextrins

  2013cites this paper
• Drug Treatment of Hypertension

  2012cites this paper
• Progress in Antihypertensive Therapy with a Multiple-Action Drug

  2012cites this paper
• Treatment of carvedilol for refractory hypertension in patients with renal diseases: A multicentre, prospective clinical trial

  2011cites this paper
• Carvedilol - a third generation beta-blocker in treating hypertension.

  2011cites this paper
• Differential effects of carvedilol and metoprolol on renal function in patients with heart failure.

  2010cites this paper
• The Autonomic Nervous System

  2010cites this paper
• Uso clínico del carvedilol en la hipertensión arterial

  2009cites this paper
• Carvedilol in hypertension treatment

  2008cites this paper
• Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease

  2008cites this paper
• Controlled-Release Carvedilol

  2008cites this paper
• Should beta-blockers be used to control hypertension in people with chronic kidney disease?

  2007cites this paper
• Comparison of Higher Dose of Losartan Treatment with Losartan Plus Carvedilol and Losartan Plus Ramipril in Patients with Glomerulonephritis and Proteinuria

  2007cites this paper
• Should β-Blockers Be Used to Control Hypertension in People With Chronic Kidney Disease?

  2007cites this paper
• Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.

  2006cites this paper
• Beta blockers in the management of chronic kidney disease.

  2006cites this paper
• Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes

  2006cites this paper
• The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics

  2005cites this paper
• Hemodynamic profile of carvedilol

  2005cites this paper
• Treatment of acute coronary syndromes in patients who have chronic kidney disease.

  2005cites this paper
• The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)—Rationale and Design

  2004cites this paper
• Clinical pharmacology of carvedilol

  2004cites this paper
• Carvedilol and the kidney

  2004cites this paper
• Antihypertensive profile of carvedilol

  2004cites this paper
• Carvedilol: β-Blockade and Beyond

  2004cites this paper
• beta-Blockers in hypertension: is carvedilol different?

  2004cites this paper
• Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.

  2003cites this paper
• Cardiovascular and renal effects of carvedilol in dogs with heart failure.

  2002cites this paper
• Salvage of Cyclosporine A-Induced Oxidative Stress and Renal Dysfunction by Carvedilol

  2002cites this paper
• Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism

  2002cites this paper
• Anti-Adrenergic Therapy in Hypertensive Patients with Concomitant Disease

  2001cites this paper
• Mechanisms and Treatment Options of Chronic Graft Dysfunction

  2001cites this paper
• Mechanisms and Treatment Options of Chronic Graft Dysfunction Experimental and Clinical Studies

  2001cites this paper
• The Effects of ß-Blockade on the Cardiovascular System — Not all ß-Blockers are Created Equal

  2001cites this paper
• β-Receptor Blocking Agents

  2000cites this paper
• Carvedilol treatment of kidney graft recipients with chronic rejection

  1999cites this paper
• Clinical Pharmacology of Carvedilol

  1999cites this paper
• Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.

  1998cites this paper
• Recent Observations With b -Adrenoceptor Blockade Beneficial Effects in Hypertension and Heart Failure

  1998cites this paper
• Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure.

  1998cites this paper
• Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population‐based sample

  1998cites this paper
• Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.

  1997cites this paper
• Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

  1997cites this paper
• Pharmacology of Carvedilol: Rationale for Use in Hypertension, Coronary Artery Disease, and Congestive Heart Failure

  1997cites this paper
• Acute haemodynamic changes after oral carvedilol, a vasolidating beta-blocker, in patients with cirrhosis

  1996cites this paper
• Recent observations with β-adrenoceptor blockade : Beneficial effects in hypertension and heart failure

  1996cites this paper
• Quality of life in hypertensive patients treated with either carvedilol or enalapril.

  1996cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Carvedilol

  1994cites this paper
• Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents.

  1993cites this paper
• Carvedilol

  1993cites this paper
• Carvedilol: A Novel Cardiovascular Drug with Multiple Actions

  1992cites this paper
• Efficacy and safety of carvedilol in renal hypertension

  1990cites this paper
• Drugs Acting on Multiple Receptors: β-Blockers with Additional Properties

  1990cites this paper
• Effects of Carvedilol on Plasma Hormonal and Biochemical Factors and Renal Function in Japanese Patients with Essential Hypertension

  1988influential citation
• Renal Vasodilatory Action of Carvedilol in the Dog

  1988cites this paper
• Choice of antihypertensive agents in hemodynamic aspects to match pathophysiology and pharmacology in essential hypertension.

  1988cites this paper